FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pharmacology, and describes combination, representing ethyl ether of (±)-11,15-dideoxy-16-methyl-16-hydroxyprostaglandin E1 and mifepristone. Said combination provides high abortive activity, it is characterized by stability during storage, low toxicity, synthetic availability.
EFFECT: invention can be used for early abortion.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ETHYL ETHER (±)-11,15-DIDEOXY-16-METHYL-16-HYDROXYPROSTAGLANDIN E AGENT WHICH EXHIBITS UTEROTONIC ACTIVITY | 2009 |
|
RU2394814C1 |
| PROSTAGLANDIN-CONTAINING PREPARATION FOR VETERINARY PURPOSE | 1997 |
|
RU2123336C1 |
| METHOD FOR PRENATAL PREPARATION OF FULL-TERM PREGNANT WOMEN WITH PREMATURE AMENORRHEA | 2009 |
|
RU2408375C1 |
| METHOD OF UTERINE CERVIX PREPARATION FOR CHILDBIRTH WITH USE OF COMBINATION OF MIFEPRISTONE AND OSMOTIC DILATORS | 2018 |
|
RU2682574C1 |
| COMBINED METHOD OF INDUCED ABORTION IN THE SECOND TRIMESTER ON MEDICAL INDICATIONS | 2016 |
|
RU2654707C1 |
| APPLICATION OF DONORS OF NITROGEN OXIDE OR INHIBITORS OF NITROGEN OXIDE FOR REGULATION OF UTERUS CERVIX OPENING AND STRETCHING | 1996 |
|
RU2199346C2 |
| METHOD FOR MEDICINAL PREPARATION FOR DELIVERY IN RISK-GROUP PREGNANT WOMEN DUE TO PROGRESSING DISORDERS OF DELIVERY ACTIVITY | 2001 |
|
RU2179024C1 |
| METHOD FOR RESTORING REPRODUCTIVE FUNCTION IN STERILE COWS | 1991 |
|
RU2050159C1 |
| USE OF MCP-1 FOR INDUCTION OF READINESS OF UTERUS CERVIX TO OPENING | 1995 |
|
RU2207873C2 |
| METHOD OF MEDICAL PREPARATION TO CHILDBIRTH OF PREGNANT OF RISK GROUP OF THE ABNORMAL BIRTH ACTIVITY DEVELOPMENT | 2010 |
|
RU2442587C1 |
